How long does Regu-Age take to reduce dark circles?

According to the manufacturer's double-blind study (n=20), measurable reduction in under-eye dark circles of approximately 32% was observed after 4 weeks of consistent topical use. Results may vary depending on the root cause of dark circles, as Regu-Age primarily targets oxidized hemoglobin pigmentation and structural skin thinning rather than melanin-based hyperpigmentation.

What is Regu-Age made from?

Regu-Age is a patented active ingredient composed of hydrolyzed rice peptides and flavonoid-rich extract from Phyllanthus emblica, commonly known as Indian gooseberry or amla. The key bioactive flavonoids include emblicanin A, emblicanin B, and ellagic acid, which provide antioxidant and anti-hemoglobin-oxidation activity alongside the collagen-stimulating rice peptides.

What concentration of Regu-Age is effective in eye creams?

In vitro fibroblast stimulation data shows approximately 200% proliferation at a 1.25% concentration of the peptide component. Manufacturer clinical studies were conducted using formulations containing Regu-Age, though the exact percentage used in finished products is typically proprietary; most commercial eye creams list it as an active at concentrations ranging from 0.5% to 2%.

Can Regu-Age reduce eye puffiness as well as dark circles?

Yes, a manufacturer in vivo study reported a 33% reduction in periorbital puffiness, attributed to the ingredient's ability to reinforce capillary wall integrity and reduce microvascular fluid leakage in the under-eye area. The Phyllanthus emblica flavonoids help neutralize reactive oxygen species that degrade capillary walls, while the peptides support the extracellular matrix structure that prevents fluid accumulation.

Is Regu-Age safe for sensitive skin around the eyes?

Regu-Age is derived from natural rice peptides and plant-based flavonoids, and no significant irritation events were reported in available manufacturer studies. However, individuals with rice protein allergies or sensitivities to Phyllanthus emblica should conduct a patch test prior to use, and the ingredient should not be applied to broken or compromised skin near the eye contour.

What is the clinical evidence quality for Regu-Age's dark circle reduction claims?

Regu-Age's ~32% dark circle reduction is supported by a manufacturer-conducted double-blind study with 20 participants over 4 weeks, which represents controlled clinical evidence. While the study design is rigorous, the sample size is relatively small; larger independent trials would strengthen confidence in efficacy claims. The ingredient also shows supporting in vitro data on fibroblast stimulation (~200% at 1.25%) and antioxidant mechanisms via SOD enzyme activity, providing mechanistic plausibility.

Who would benefit most from Regu-Age supplementation in skincare products?

Regu-Age is most beneficial for individuals with under-eye dark circles and puffiness, as clinical data show ~32–33% improvements in both conditions within 4 weeks. Those seeking improved skin texture and dermal firmness may also benefit, given the ingredient's demonstrated ability to stimulate fibroblast proliferation and improve texture by >30%. People with aging or depleted eye area skin, and those sensitive to harsh treatments, are ideal candidates given its documented safety profile for delicate eye areas.

How does Regu-Age's mechanism of action work to improve under-eye appearance?

Regu-Age combines peptides and flavonoids to work through multiple pathways: the peptide component stimulates fibroblast proliferation (by ~200% in vitro), promoting collagen and structural renewal that firms the eye area, while flavonoids provide antioxidant protection via SOD enzyme activity to reduce oxidative stress-driven pigmentation and puffiness. This dual mechanism addresses both the structural (skin thickness and firmness) and inflammatory/oxidative components that contribute to dark circles and swelling, delivering the observed 32–33% clinical improvements.

Regu-Age (Peptides and Flavonoids)

Regu-Age is a patented cosmetic active combining rice peptides and Phyllanthus emblica (Indian gooseberry) flavonoids designed to target periorbital aging. It works by stimulating fibroblast proliferation, reinforcing the extracellular matrix, and reducing hemoglobin oxidation responsible for dark circle discoloration.

Category: Other Evidence: 2/10 Tier: Emerging

Regu-Age (Peptides and Flavonoids) — Hermetica Encyclopedia

Origin & History

Regu-Age is a branded cosmetic ingredient complex developed by DSM-Firmenich, consisting of purified natural peptides from soy (Glycine Soja Protein) and rice (Hydrolyzed Rice Protein), combined with biotechnologically produced superoxide dismutase (SOD) from yeast strains. The soy and rice peptides are extracted from plant sources, while SOD is manufactured via biotechnology, formulated as an aqueous solution for topical skincare applications.

Historical & Cultural Context

No historical or traditional medicinal use is documented for Regu-Age. It is a modern branded cosmetic active developed through biotechnology and plant extraction, with no ties to traditional medicine systems like Ayurveda, TCM, or folk medicine.

Health Benefits

• Reduces under-eye dark circles by ~32% after 4 weeks (manufacturer double-blind study, n=20)
• Decreases eye puffiness by 33% (manufacturer in vivo study)
• Improves skin texture by >30% in 4 weeks (consumer study)
• Stimulates fibroblast proliferation by ~200% at 1.25% concentration (in vitro study)
• Provides antioxidant protection through SOD enzyme activity (in vitro mechanism study)

How It Works

Regu-Age's rice-derived peptides stimulate fibroblast proliferation by approximately 200% at a 1.25% concentration in vitro, promoting collagen and elastin synthesis to restore dermal density around the eye. The Phyllanthus emblica flavonoids—primarily emblicanin A, emblicanin B, and ellagic acid—act as potent antioxidants that inhibit hemoglobin oxidation and reduce iron-mediated free radical damage in the periorbital microvasculature, directly addressing pigmentation from blood stasis. Together, these actives reinforce the capillary walls and extracellular matrix, reducing fluid accumulation that drives puffiness.

Scientific Research

Clinical evidence is limited to manufacturer-conducted studies with no PubMed PMIDs or peer-reviewed RCTs identified. A double-blind in vivo study with 20 subjects using 5% REGU-AGE PF cream showed 32% reduction in dark circles and 33% reduction in puffiness after 4 weeks, though these are small-scale manufacturer studies rather than independent clinical trials.

Clinical Summary

The primary clinical evidence comes from a manufacturer-sponsored double-blind study (n=20) showing a ~32% reduction in under-eye dark circles after 4 weeks of topical application. A separate manufacturer-conducted in vivo study reported a 33% decrease in eye puffiness, and a consumer-use study documented greater than 30% improvement in periorbital skin texture within the same timeframe. An in vitro study demonstrated ~200% stimulation of fibroblast proliferation at a 1.25% concentration. While results are promising, the evidence base is limited by small sample sizes, manufacturer funding, and the absence of large independent randomized controlled trials.

Nutritional Profile

Regu-Age is a cosmetic active ingredient complex, not a nutritional supplement, so traditional macronutrient/micronutrient profiling does not apply. Its bioactive composition consists of two primary component classes: (1) Peptides — derived from rice bran and soy protein hydrolysates, including low-molecular-weight oligopeptides that interact with extracellular matrix proteins and stimulate fibroblast proliferation (~200% increase demonstrated at 1.25% concentration in vitro); (2) Flavonoids — sourced from Pycnogenus (pine bark) and/or citrus-derived bioflavonoids, including compounds such as hesperidin and related polyphenols known to support capillary integrity and microcirculation, contributing to reduction of hemoglobin oxidation byproducts responsible for dark circles. The active complex is typically supplied at 1–3% concentration in finished formulations. Antioxidant activity is mechanistically linked to upregulation of superoxide dismutase (SOD) enzyme activity, indicating an indirect antioxidant pathway rather than direct radical scavenging. Bioavailability in the nutritional sense is not characterized, as delivery is topical/transdermal; skin penetration efficacy is the relevant bioavailability metric, facilitated by the low molecular weight of the peptide fractions. No caloric value, dietary fiber, vitamins, or minerals are present as functional components of this ingredient.

Preparation & Dosage

Topical application: 2-5% concentration in cosmetic formulations (eye creams or serums), with 5% showing optimal efficacy in manufacturer studies over 4-8 weeks. Supplied as aqueous solution, water-soluble, for incorporation into water-based formulations only. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Retinol, Caffeine, Hyaluronic Acid, Niacinamide

Safety & Interactions

Regu-Age is formulated exclusively as a topical cosmetic ingredient and has no established systemic absorption profile, making drug interactions highly unlikely under normal use conditions. No significant adverse effects have been reported in available manufacturer studies; however, individuals with known allergies to rice proteins or Phyllanthus emblica (Indian gooseberry) should perform a patch test before broader application. Safety data for use during pregnancy or breastfeeding is not available, and cautious avoidance is advisable given the lack of dedicated studies in those populations. It should not be applied to broken or severely compromised skin around the eye area.